ZYXI Zynex Inc
Price (delayed)
$2.18
Market cap
$69.57M
P/E Ratio
24.22
Dividend/share
N/A
EPS
$0.09
Enterprise value
$103.35M
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery
Highlights
The P/E is 63% below the last 4 quarters average of 64.6 and 49% below the 5-year quarterly average of 47.2
The gross profit has grown by 4.8% YoY
ZYXI's quick ratio is up by 15% QoQ but it is down by 11% YoY
Zynex's net income has plunged by 69% YoY and by 38% from the previous quarter
The EPS has plunged by 67% YoY and by 36% from the previous quarter
Key stats
What are the main financial stats of ZYXI
Market
Valuations
Earnings
Shares outstanding
31.91M
Market cap
$69.57M
Enterprise value
$103.35M
Price to earnings (P/E)
24.22
Price to book (P/B)
1.94
Price to sales (P/S)
0.36
EV/EBIT
17.2
EV/EBITDA
10.59
EV/Sales
0.54
Revenue
$192.35M
Gross profit
$152.93M
Operating income
$5.99M
Net income
$2.99M
EBIT
$6.01M
EBITDA
$9.76M
Free cash flow
$12.14M
Per share
Balance sheet
Liquidity
EPS
$0.09
EPS diluted
$0.09
Free cash flow per share
$0.38
Book value per share
$1.12
Revenue per share
$6.02
TBVPS
$2.96
Total assets
$122.08M
Total liabilities
$86.37M
Debt
$73.82M
Equity
$35.71M
Working capital
$58.32M
Debt to equity
2.07
Current ratio
4.46
Quick ratio
3.44
Net debt/EBITDA
3.46
Margins
Efficiency
Dividend
EBITDA margin
5.1%
Gross margin
79.5%
Net margin
1.6%
Operating margin
3.1%
Return on assets
2.4%
Return on equity
8.7%
Return on invested capital
5.2%
Return on capital employed
5.7%
Return on sales
3.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZYXI stock price
How has the Zynex stock price performed over time
Intraday
1.4%
1 week
1.4%
1 month
-24.83%
1 year
-81.94%
YTD
-72.78%
QTD
-0.91%
Financial performance
How have Zynex's revenue and profit performed over time
Revenue
$192.35M
Gross profit
$152.93M
Operating income
$5.99M
Net income
$2.99M
Gross margin
79.5%
Net margin
1.6%
The net margin has plunged by 70% YoY and by 36% from the previous quarter
Zynex's net income has plunged by 69% YoY and by 38% from the previous quarter
Zynex's operating margin has decreased by 47% YoY and by 33% QoQ
The company's operating income fell by 44% YoY and by 32% QoQ
Growth
What is Zynex's growth rate over time
Valuation
What is Zynex stock price valuation
P/E
24.22
P/B
1.94
P/S
0.36
EV/EBIT
17.2
EV/EBITDA
10.59
EV/Sales
0.54
The EPS has plunged by 67% YoY and by 36% from the previous quarter
The P/E is 63% below the last 4 quarters average of 64.6 and 49% below the 5-year quarterly average of 47.2
The P/B is 78% less than the last 4 quarters average of 8.9 and 77% less than the 5-year quarterly average of 8.5
The equity has declined by 23% year-on-year
The price to sales (P/S) is 90% lower than the 5-year quarterly average of 3.7 and 78% lower than the last 4 quarters average of 1.6
Zynex's revenue has increased by 4.4% YoY
Efficiency
How efficient is Zynex business performance
ZYXI's ROA has dropped by 66% year-on-year and by 37% since the previous quarter
The ROIC has plunged by 58% YoY and by 31% from the previous quarter
The ROS has plunged by 58% YoY and by 33% from the previous quarter
ZYXI's ROE is down by 48% year-on-year and by 34% since the previous quarter
Dividends
What is ZYXI's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Zynex financials performed over time
The total assets is 41% more than the total liabilities
ZYXI's quick ratio is up by 15% QoQ but it is down by 11% YoY
ZYXI's current ratio is up by 13% from the previous quarter but it is down by 6% YoY
The debt is 107% more than the equity
Zynex's debt to equity has increased by 25% YoY
The equity has declined by 23% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.